Key takeaway

When parties shake hands on a deal but sign a contract that says something different, which controls? Joseph Beard claimed an oral agreement entitled him to millions from a multi-billion-dollar company sale, but the written agreements he signed said otherwise.

By Chris Bankler

When parties shake hands on a deal but sign a contract that says something different, which controls? Joseph Beard claimed an oral agreement entitled him to millions from a multi-billion-dollar company sale, but the written agreements he signed said otherwise. In Beard v. Perot, the Texas Business Court held him to those writings, explaining that “reliance disclaimers, merger clauses, and broad releases exist to bring certainty and finality to their parties’ agreements and relationships and avoid future disputes.”

Background

Joseph Beard joined Perot Jain, L.P., an early-stage venture capital firm, in 2015 as its first “partner.” His employment agreement made him eligible for a three-percent “promote” based on his involvement with portfolio companies, including Access Healthcare, where he served as U.S.-based Senior Vice President of Corporate Development for more than four years.

When Beard left Perot Jain in 2020, the parties entered into a Separation Agreement under which Beard retained a vested carried interest in 37 specifically identified portfolio companies. Access Healthcare was not among them. Beard alleged, however, that Access Healthcare was intentionally excluded based on an oral “handshake agreement” that his interest would be paid later, after the parties could value the company.

The Separation Agreement included a broad release of employment-related claims, including claims for “profit participations” and other compensation. It also contained merger and no-reliance provisions under which Beard agreed there were “no other agreements, statements, promises, or representations” between the parties. More than two years later, Perot Jain paid Beard $270,000 under a Release Agreement to purchase his interests in the listed companies; that agreement also contained merger and reliance-disclaimer provisions.

In January 2025, Access Healthcare was sold in a multi-billion-dollar transaction. When Beard requested payment, defendants refused and denied that the handshake agreement existed. Beard sued for fraudulent inducement, promissory estoppel, quantum meruit, and breach of contract. Defendants moved to dismiss under Rule 91a.

The Court’s Rulings

The Separation Agreement Released Beard’s Access Healthcare Claims

The Court first determined that the Separation Agreement’s broad release encompassed Beard’s Access Healthcare claims. Beard argued the release did not apply because Access Healthcare was excluded from the list of companies for which he would receive a promotion.

Although a general release is narrowly construed, a release can encompass claims falling within a category specifically identified in the agreement. Here, the release covered all claims relating to Beard’s employment and separation, including claims for “profit participations” and “compensation of any nature other than wages,” whether “actual or potential.”

Considering the release in context, the Court noted that Access Healthcare was expressly identified as a released party yet omitted from the list of companies in which Beard retained a carried interest. The agreement also provided that Beard had been paid all amounts owed except for the compensation expressly identified.

Together, those provisions established “the parties’ objective intent that the release’s scope includes all possible Access Healthcare claims.” The release therefore barred Beard’s claims based on his alleged Access Healthcare interest, except for his contention that the Separation Agreement itself was fraudulently induced.

Three Doctrines Defeated Beard’s Fraudulent-Inducement Claim

The Court next considered whether Beard could avoid the Separation Agreement by alleging fraudulent inducement. A contractual release does not necessarily bar a claim that the contract containing the release was itself fraudulently induced, and a merger or no-other-representations clause, standing alone, does not necessarily preclude fraudulent inducement.

But fraudulent inducement requires justifiable reliance. The Court identified three doctrines under Texas law that can make reliance on an extracontractual promise unjustifiable as a matter of law: “(i) the red flags doctrine, (ii) the direct contradiction rule, and (iii) reliance disclaimers.”  Those doctrines “may operate independently or together depending on the facts.” Here, “all three lines apply.”

First, under the red-flags doctrine, courts consider the circumstances surrounding the alleged representation, including the sophistication of the parties. A sophisticated party “should be expected to recognize red flags that the less experienced may overlook,” while a party engaged in arm’s-length negotiation “must exercise ordinary care for the protection of his interests.”

Second, under the direct-contradiction rule, reliance on an oral promise that directly conflicts with an express and unambiguous contractual provision is unjustifiable as a matter of law. The Court relied on the Texas Supreme Court’s recent decision in Roxo Energy Co. v. Baxsto, which held that the absence of a previously discussed promise from the written agreement can itself constitute a red flag. As the Supreme Court explained, “[t]he prudent response is to demand that the parties’ discussions be reflected in the writing—not to sign an agreement that makes no mention of the promises and then try to hold your counterparty to them anyway.”

Third, an enforceable reliance disclaimer may independently defeat a fraudulent-inducement claim. The Court distinguished an ordinary merger clause from an express agreement not to rely on extracontractual representations. Under Forest Oil Corp. v. McAllen and Schlumberger Technology Corp. v. Swanson, an unambiguous waiver of reliance negotiated by sophisticated parties in an arm’s-length transaction may conclusively negate reliance.

Applying those doctrines, the Court found that Beard could not justifiably rely on the alleged handshake agreement. The Court identified several conflicts between that alleged promise and the Separation Agreement: the written agreement provided that Beard’s future carry applied only to companies identified on Schedule A, which did not include Access Healthcare; the merger clause stated that there were no other promises between the parties; Beard expressly disclaimed reliance on extracontractual promises; and he broadly released existing and potential claims except for the interests preserved in the agreement.

Thus, Beard’s alleged oral promise did not merely concern something the written contract failed to address; it directly conflicted with the contract’s terms. As Judge Whitehill summarized, “[c]ourts conclude that there is no justifiable reliance as a matter of law when the plain language of a written agreement contradicts an alleged prior oral agreement.”

Moreover, “[t]he contradictory text is itself a red flag alerting a party that the oral discussions may no longer be part of the deal.” The Court therefore concluded that the reliance disclaimers, direct contradictions, and surrounding red flags each supported dismissal.

Key Takeaways

  1. If you want to defeat a later fraud claim, use an express no-reliance clause. A merger clause says the writing is the parties’ final agreement. A no-reliance clause goes further by addressing an element of fraud itself. Beard shows why sophisticated commercial agreements should include both, particularly when the parties have had extensive negotiations or prior discussions that are not reflected in the final agreement.
  2. On a Rule 91a motion, attack reliance from three directions. Judge Whitehill identified three distinct paths for establishing that reliance on an extracontractual promise was unjustifiable: red flags, direct contradiction, and reliance disclaimers. Defendants should consider all three rather than relying exclusively on the contract’s merger or no-reliance language. Plaintiffs should plead with those doctrines in mind, particularly when the alleged representation conflicts with, or is conspicuously absent from, an attached agreement.
  3. If a negotiated promise matters, put it in the contract. Here, the parties specifically addressed which portfolio companies would generate future compensation, but Access Healthcare was not on the list. As Judge Whitehill explained, contradictory contractual language can itself be “a red flag alerting a party that the oral discussions may no longer be part of the deal.” For deal lawyers and litigators alike, the practical lesson is simple: an important promise discussed during negotiations but missing from the final agreement may be very difficult to enforce later.

The opinions expressed are those of the authors and do not necessarily reflect the views of the firm, its clients, or any of its or their respective affiliates. This article is for informational purposes only and does not constitute legal advice. For more information, please contact Chris Bankler or a member of the Trial & Appellate Litigation practice.


Meet Chris

Chris Bankler focuses on the resolution of disputes for businesses and financial institutions. He counsels clients through the process of complex business litigation, including general business disputes, fraud claims, breach of fiduciary duty cases, and complex business bankruptcy litigation. He has served as litigation counsel in more than 100 cases in state and federal courts, as well as FINRA and AAA arbitrations.

The opinions expressed are those of the authors and do not necessarily reflect the views of the firm, its clients, or any of its or their respective affiliates. This article is for informational purposes only and does not constitute legal advice. For more information, please contact Chris Bankler or a member of the Trial & Appellate Litigation practice.